A Case of Olanzapine-Induced Fever
By Cho-Hsiang Yang, Ying-Yeh Chen
-
Opium Withdrawal Delirium: Two Case Reports
By Ravi C. Sharma, Ramesh Kumar, Dinesh Dutt Sharma, Pankaj Kanwar
-
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders By A. Zarina Kraal, Kristen M. Ward, Vicki L. Ellingrod -
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention By James W. Price -
ORIGINAL RESEARCH Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study By Stella S. Tang, Leanna Jaward, Kristen Ward, Sagar V. Parikh, Jolene R. Bostwick -
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety and Safety By Matthew T. Morris, Sandip P. Tarpada -
Aripiprazole-induced Asymptomatic Hypertension: A Case Report by Hilal Seven, Medine Giynaş Ayhan, Ayşe Kürkcü, Süleyman Özbek, İbrahim Eren -
Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-resistant Schizophrenia by Ruth Rayikanti, Iga Lentowicz, Badari Birur, Li Li -
This product is the full issue of Psychopharmacology Bulletin VOL 47 No. 2. Upon purchase, you will receive a single downloadable PDF file with all this issues articles stacked from front cover to back cover. -
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
By Christoph U. Correll, Richard C. Josiassen, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
-
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
By Richard C. Josiassen, John M. Kane, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
By John M. Kane, Christoph U. Correll, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
-
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects
By Rosa Luo, Haig Bozigian, Roland Jimenez, Gordon Loewen, Christopher F. O’Brien
-
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
By Henry A. Nasrallah, Ralph Aquila, Arielle D. Stanford, Hasan H. Jamal, Peter J. Weiden, Robert Risinger
-
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
By Robert Risinger, Marjie Hard, Peter J. Weiden
-
This product is the full issue of Psychopharmacology Bulletin VOL 47 No. 3. Upon purchase, you will receive a single downloadable PDF file with all this issues articles stacked from front cover to back cover.
